Hedge Fund - MSDC Management
Halozyme Therapeutics Inc (HALO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2018 - Q4 (2018-12-31) | $0 | 0% | 0 | $15.95 |
| 2 | 2018 - Q3 (2018-09-30) | $40,792,000 | 3.07% | 2,245,000 | $17.52 |
| 3 | 2018 - Q2 (2018-06-30) | $37,873,000 | 1.62% | 2,245,000 | $18.91 |
| 4 | 2018 - Q1 (2018-03-31) | $43,980,000 | 2.23% | 2,245,000 | $19.37 |
| 5 | 2017 - Q4 (2017-12-31) | $45,484,000 | 2.36% | 2,245,000 | $18.38 |
| 6 | 2017 - Q3 (2017-09-30) | $38,996,000 | 1.13% | 2,245,000 | $13.54 |
| 7 | 2017 - Q2 (2017-06-30) | $28,781,000 | 1.79% | 2,245,000 | $13.36 |
| 8 | 2017 - Q1 (2017-03-31) | $9,914,000 | 0.49% | 765,000 | $12.64 |
| 9 | 2016 - Q4 (2016-12-31) | $9,534,000 | 0.47% | 965,000 | $10.95 |
| 10 | 2016 - Q3 (2016-09-30) | $11,657,000 | 0.94% | 965,000 | $10.22 |
| 11 | 2016 - Q2 (2016-06-30) | $8,328,000 | 0.54% | 965,000 | $9.87 |
| 12 | 2016 - Q1 (2016-03-31) | $8,712,000 | 0.45% | 920,000 | $9.41 |
The displayed share prices are average quarterly stock market prices.